The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Dolphin Medical Services Ltd

Dolphin Medical Services Ltd

BSE 526504 · NSE DOLPHMED · ISIN INE796B01013 · Group XT · Suspended

Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider

₹6.98

-3.06%

BSE close, 28 August 2026

Market cap

₹10.54 cr

1.5 cr shares · Micro cap

Free float

₹7.66 cr

as published

P/E · P/B

232.7× · 1.03×

EPS ₹0.03 · BV ₹6.78

FY25-26 rev / PAT

0.75 / 0.04

₹ cr, as filed

Filings, window

10

5 selected · 50%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹1.98 52-WK HIGH ₹9.57 ₹6.98 66% of range
Against 52-week high-27.1%
Against 52-week low+252.5%
Day change-3.06%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.03
Price / earnings232.67×
Price / book1.03×
Book value — derived, price ÷ P/B₹6.78
Return on equity0.47%
Operating margin19.90%
Net margin8.74%

Consistency check

P/B ÷ P/E, which must equal ROE
0.44%
ROE as published
0.47%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 0.21 0.02 0.11 19.90% 8.74%
Mar-26 · Q 0.19 0.01 0.01 16.67% 3.65%
FY25-26 0.75 0.04 0.02 21.47% 5.60%

Quarter on quarter

Revenue, quarter on quarter
+10.5%
Net profit, quarter on quarter
+100.0%
Operating margin, quarter on quarter
+323 bps

Disclosure profile 10 filings in the window

0 median 17.0 p75 · 25 sector max 52 10 16th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Change in Control1
Change in Management1
Open Offer1
Results1
Selected sub-total5
Procedural
General4
Trading Window1
Procedural sub-total5
Total10

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

10 filings · 5 selected · busiest 2026-08-14 and 2026-09-21

Filing rhythm · the twelve most recent

2026-07-272026-09-30

SelectedProcedural

Filings

10 in the window · 2 earlier on record

  1. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Wndow

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 21 September 2026 ·

    Change in Management

    Change in Management

    BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters

    Company Update / Change in Management View filing →

  3. 21 September 2026 ·

    Change in Control

    Change in Management Control

    BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters

    Company Update / Change in Management Control View filing →

  4. 3 September 2026 ·

    General

    Intimation Of Extension Of AGM

    Intimation of Extension of AGM

    Company Update / General View filing →

  5. 28 August 2026 ·

    General

    Post-Offer Advertisement

    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms of the Securities and Exchange Board ....

    Company Update / General View filing →

  6. 14 August 2026 ·

    Results

    Results: Unaudited Financial Results For The Quarter Ended June 30, 2026

    Results

    Result / Financial Results View filing →

  7. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026

    Board meeting outcome

    Board Meeting / Outcome of Board Meeting View filing →

  8. 30 July 2026 ·

    Open Offer

    Updates on Open Offer

    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Announcement and Detailed Public Statement ....

    Company Update / Open Offer View filing →

  9. 29 July 2026 ·

    General

    Recommendations of the Committee of Independent Directors ('IDC')

    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors ('IDC') of Dolphin Medical Services ....

    Company Update / General View filing →

  10. 27 July 2026 ·

    General

    Letter of Offer

    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer ("LOF") to the public shareholders of Dolphin Medical Services Ltd ("Target Company").

    Company Update / General View filing →

RSS feed for Dolphin Medical Services Ltd · the 50 most recent filings